Precigen, Inc.
PGEN
$4.76
-$0.08-1.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 206.93% | 16.76% | 24.69% | -3.76% | -30.91% |
| Total Other Revenue | -- | 161.54% | 187.50% | 266.67% | 0.00% |
| Total Revenue | 206.61% | 19.39% | 25.92% | -3.09% | -30.89% |
| Cost of Revenue | 8.34% | -19.60% | 2.33% | 8.54% | 705.40% |
| Gross Profit | 8.19% | 42.56% | 2,510.00% | -8.83% | -7,131.65% |
| SG&A Expenses | 143.91% | 56.54% | 21.75% | 7.16% | 6.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.37% | 6.29% | -6.04% | -2.80% | -0.45% |
| Operating Income | -62.17% | -5.94% | 7.43% | 2.79% | -1.55% |
| Income Before Tax | -510.63% | 55.95% | -127.85% | 40.66% | -21.03% |
| Income Tax Expenses | -- | 100.18% | -- | 73.80% | 300.00% |
| Earnings from Continuing Operations | -510.33% | 54.68% | -128.13% | 40.32% | -21.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -510.33% | 54.68% | -128.13% | 40.32% | -21.13% |
| EBIT | -62.17% | -5.94% | 7.43% | 2.79% | -1.55% |
| EBITDA | -63.58% | -10.23% | 3.72% | -1.38% | -6.75% |
| EPS Basic | -1,118.87% | 61.42% | -93.59% | 49.32% | -9.03% |
| Normalized Basic EPS | -448.43% | 25.39% | -93.29% | 15.19% | -9.04% |
| EPS Diluted | -1,118.87% | 61.42% | -93.59% | 49.32% | -9.03% |
| Normalized Diluted EPS | -448.43% | 25.39% | -93.29% | 15.19% | -9.04% |
| Average Basic Shares Outstanding | 11.34% | 17.46% | 17.92% | 17.77% | 11.01% |
| Average Diluted Shares Outstanding | 11.34% | 17.46% | 17.92% | 17.77% | 11.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |